Deferasirox Tablet, For Suspension
Product Images NDC 69539-022

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 69539-022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Msn Laboratories Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

125mg 100s Blister Carton

Deferasirox Tablets for Oral Suspension 125 mg per tablet carton from MSN Laboratories Private Limited. The label indicates 100 tablets in 10 unit-dose packs, with storage instructions and caution not to chew or swallow whole. The product is for institutional use only and distributed by MSN Pharmaceuticals Inc.*

FDA Label Image

125mg 10s Blister Foil

Deferasirox Tablet for Oral Suspension 125 mg per tablet labels arranged in two columns and five rows on a sheet. Each label includes the NDC 69539-021-11, manufacturer MSN Laboratories Private Limited, and states 'For Institutional Use Only' with barcode and instructions to push the tablet through foil. The product is made in India.*

FDA Label Image

250mg 100s Blister Carton

Deferasirox Tablets for Oral Suspension 250 mg per tablet, presented in a carton for 100 tablets (10 x 10 unit-dose) by MSN Laboratories Private Limited. The label includes storage instructions, manufacturer and distributor details, and usage warnings indicating it is for institutional use only and must be dispersed in water, orange, or apple juice prior to ingestion.*

FDA Label Image

250mg 10s Blister Foil

Blister card packaging for Deferasirox Tablet for Oral Suspension, 250 mg per tablet, by MSN Laboratories Private Limited. The label includes the NDC 69539-022-11, barcode, and instructions to push the tablet through the foil. It is marked for institutional use only and states the product is made in India. Multiple identical dose units are shown on the foil.*

FDA Label Image

500mg 100s Blister Carton Label

Packaging label for Deferasirox Tablets for Oral Suspension 500 mg per tablet. The box contains 100 tablets in 10 unit-dose strips. The label includes instructions to not chew or swallow whole, with tablets to be dispersed in water, orange, or apple juice. It is marked for institutional use only and Rx only. Manufactured by MSN Laboratories Private Limited and distributed by MSN Pharmaceuticals Inc.*

FDA Label Image

500mg 10s Blister Foil

Deferasirox 500 mg Tablet for Oral Suspension label with NDC 69539-023-11. The label states the product is for institutional use only, manufactured by MSN Laboratories Private Limited in India. Each label includes a barcode, space for lot number and expiration date, and instructions to push the tablet through foil. Multiple identical labels are shown in a sheet format.*

FDA Label Image

125mg-1000s (Deferasirox 125mg 1000s Count)

Label for Deferasirox Tablets for Oral Suspension, 125 mg per tablet, oral dosage form. The label includes storage instructions, manufacturer and distributor details (MSN Laboratories Private Limited, INDIA; MSN Pharmaceuticals Inc, Piscataway, NJ), and a quantity of 1000 tablets. It also states the tablet must be dispersed in water or juice before ingestion and is marked Rx Only.*

FDA Label Image

125mg-30s (Deferasirox 125mg 30s Count)

Deferasirox Tablets for Oral Suspension 125 mg per tablet package label. The label indicates the drug is manufactured by MSN Laboratories Private Limited and distributed by MSN Pharmaceuticals Inc. It includes storage instructions, a barcode, and a count of 30 tablets. Dosage instructions advise dispersing tablets in water, orange, or apple juice before ingestion. The label is in English and marked Rx Only.*

FDA Label Image

125mg-90s (Deferasirox 125mg 90s Count)

Label for Deferasirox Tablets for Oral Suspension, 125 mg per tablet. The label states the tablets must be dispersed in water, orange, or apple juice before ingestion and not swallowed whole. It includes storage instructions and manufacturer details, MSN Laboratories Private Limited, Telangana, India, with distribution by MSN Pharmaceuticals Inc., Piscataway, NJ. The package contains 90 tablets.*

FDA Label Image

250mg-1000s (Deferasirox 250mg 1000s Count)

Label for Deferasirox Tablets for Oral Suspension 250 mg per tablet, oral dosage form, from MSN Laboratories Private Limited. The label includes storage instructions (20°C to 25°C), a barcode, manufacturer and distributor details, and states the package contains 1000 tablets. It advises tablets must be dispersed in water, orange, or apple juice prior to ingestion and warns not to swallow whole.*

FDA Label Image

250mg-30s (Deferasirox 250mg 30s Count)

Label for Deferasirox Tablets for Oral Suspension 250 mg per tablet, featuring storage instructions, warnings to keep out of reach of children, and directions that tablets must be dispersed in water, orange, or apple juice before ingestion. Manufactured by MSN Laboratories Private Limited in India and distributed by MSN Pharmaceuticals Inc. in New Jersey, USA. The package contains 30 tablets.*

FDA Label Image

250mg-90s (Deferasirox 250mg 90s Count)

Label for Deferasirox Tablets for Oral Suspension, 250 mg per tablet, manufactured by MSN Laboratories Private Limited and distributed by MSN Pharmaceuticals Inc. The label provides storage instructions, dosage information, and a warning not to chew or swallow the tablet whole. Contains 90 tablets per package with NDC 69539-022-90.*

FDA Label Image

500mg-30s (Deferasirox 500mg 30s Count)

Label for Deferasirox Tablets for Oral Suspension, 500 mg per tablet, shown as a 30-tablet package. The label includes storage instructions, manufacturer MSN Laboratories Private Limited, and distributor MSN Pharmaceuticals Inc. Directions note tablets must be dispersed in water, orange, or apple juice before ingestion. The product is Rx only.*

FDA Label Image

500mg-500s (Deferasirox 500mg 500s Count)

Deferasirox Tablets for Oral Suspension, 500 mg per tablet, label from MSN Laboratories Private Limited. The label includes storage instructions (20°C to 25°C), a cautions section about not chewing or swallowing whole, and a note for pharmacists to dispense the medication guide. The package contains 500 tablets and is marked Rx only with NDC 69539-023-05.*

FDA Label Image

500mg-90s (Deferasirox 500mg 90s Count)

Label for Deferasirox Tablets for Oral Suspension, 500 mg per tablet, by MSN Laboratories Private Limited. The label includes storage instructions, a barcode, manufacturer and distributor information, Rx only designation, and quantity of 90 tablets. It advises tablets must be dispersed in water, orange, or apple juice prior to ingestion and notes to dispense the accompanying Medication Guide.*

FDA Label Image

Fig-01 (Deferasirox Figure 1)

A bar chart showing the effect of different doses of Deferasirox tablets (measured in mg/kg/day) on liver iron content and serum ferritin levels. The x-axis represents Deferasirox dosage (5, 10, 20, 30 mg/kg/day), while the y-axes show changes in liver iron content (mg Fe/g dry weight) on the left and serum ferritin (mcg/L) on the right. Data bars indicate dose-related changes with sample sizes noted below each dose.*

FDA Label Image

Str (Deferasirox Structure)

Chemical structure of deferasirox, showing its molecular arrangement with multiple phenol groups and nitrogen atoms in heterocyclic rings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.